632 related articles for article (PubMed ID: 10101034)
1. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J
Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034
[TBL] [Abstract][Full Text] [Related]
2. 4-trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor kappaB activation.
Bayón Y; Alonso A; Sánchez Crespo M
Br J Pharmacol; 1999 Mar; 126(6):1359-66. PubMed ID: 10217529
[TBL] [Abstract][Full Text] [Related]
3. Effect of 4-trifluoromethyl derivatives of salicylate on nuclear factor kappaB-dependent transcription in human astrocytoma cells.
Hernández M; de Arriba AF; Merlos M; Fuentes L; Crespo MS; Nieto ML
Br J Pharmacol; 2001 Jan; 132(2):547-55. PubMed ID: 11159705
[TBL] [Abstract][Full Text] [Related]
4. Salicylate metabolites inhibit cyclooxygenase-2-dependent prostaglandin E(2) synthesis in murine macrophages.
Hinz B; Kraus V; Pahl A; Brune K
Biochem Biophys Res Commun; 2000 Jul; 274(1):197-202. PubMed ID: 10903918
[TBL] [Abstract][Full Text] [Related]
5. Aspirin and other cyclooxygenase inhibitors: new therapeutic insights.
Wu KK
Semin Vasc Med; 2003 May; 3(2):107-12. PubMed ID: 15199473
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation.
Michaluart P; Masferrer JL; Carothers AM; Subbaramaiah K; Zweifel BS; Koboldt C; Mestre JR; Grunberger D; Sacks PG; Tanabe T; Dannenberg AJ
Cancer Res; 1999 May; 59(10):2347-52. PubMed ID: 10344742
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cardiac hypertrophy by triflusal (4-trifluoromethyl derivative of salicylate) and its active metabolite.
Planavila A; Rodríguez-Calvo R; de Arriba AF; Sánchez RM; Laguna JC; Merlos M; Vazquez-Carrera M
Mol Pharmacol; 2006 Apr; 69(4):1174-81. PubMed ID: 16421291
[TBL] [Abstract][Full Text] [Related]
8. Absence of nuclear factor kappaB inhibition by NSAIDs in hepatocytes.
Callejas NA; Casado M; Boscá L; Martín-Sanz P
Hepatology; 2002 Feb; 35(2):341-8. PubMed ID: 11826407
[TBL] [Abstract][Full Text] [Related]
9. Platelet antiaggregatory effect of triflusal in human whole blood.
de la Cruz JP; Pavia J; Bellido I; González MC; Sánchez de la Cuesta F
Methods Find Exp Clin Pharmacol; 1988 Apr; 10(4):273-7. PubMed ID: 3386335
[TBL] [Abstract][Full Text] [Related]
10. Effects of the nuclear factor-kappaB inhibitors 2-hydroxy-4-trifluoromethylbenzoic acid and aspirin on micturition in rats with normal and inflamed bladder.
Velasco C; Angelico P; Guarneri L; Leonardi A; Clarke DE; Testa R
J Urol; 2001 Nov; 166(5):1962-8. PubMed ID: 11586268
[TBL] [Abstract][Full Text] [Related]
11. Sodium salicylate inhibits prostaglandin formation without affecting the induction of cyclooxygenase-2 by bacterial lipopolysaccharide in vivo.
Giuliano F; Mitchell JA; Warner TD
J Pharmacol Exp Ther; 2001 Dec; 299(3):894-900. PubMed ID: 11714873
[TBL] [Abstract][Full Text] [Related]
12. Effect of triflusal and acetylsalicylic acid on platelet aggregation in human whole blood: influence of red blood cells and leukocytes.
de la Cruz JP; Pavia J; Bellido I; Sánchez de la Cuesta F
Methods Find Exp Clin Pharmacol; 1988 Jun; 10(6):363-7. PubMed ID: 3412046
[TBL] [Abstract][Full Text] [Related]
13. Origins of prostaglandin E2: involvements of cyclooxygenase (COX)-1 and COX-2 in human and rat systems.
Giuliano F; Warner TD
J Pharmacol Exp Ther; 2002 Dec; 303(3):1001-6. PubMed ID: 12438520
[TBL] [Abstract][Full Text] [Related]
14. Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy.
Zheng L; Howell SJ; Hatala DA; Huang K; Kern TS
Diabetes; 2007 Feb; 56(2):337-45. PubMed ID: 17259377
[TBL] [Abstract][Full Text] [Related]
15. Levamisole modulates prostaglandin E2 production and cyclooxygenase II gene expression in human colonic cancer cells.
Liu CY; Lai YY; Lo CJ
J Surg Res; 2004 Apr; 117(2):223-31. PubMed ID: 15047127
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 production dependent upon cyclooxygenase-1 and cyclooxygenase-2 and its contradictory modulation by auranofin in rat peritoneal macrophages.
Yamada M; Niki H; Yamashita M; Mue S; Ohuchi K
J Pharmacol Exp Ther; 1997 May; 281(2):1005-12. PubMed ID: 9152412
[TBL] [Abstract][Full Text] [Related]
17. Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes.
Blanco FJ; Guitian R; Moreno J; de Toro FJ; Galdo F
J Rheumatol; 1999 Jun; 26(6):1366-73. PubMed ID: 10381057
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs.
Giuliano F; Warner TD
Br J Pharmacol; 1999 Apr; 126(8):1824-30. PubMed ID: 10372826
[TBL] [Abstract][Full Text] [Related]
19. Effect of retinoids on LPS-induced COX-2 expression and COX-2 associated PGE(2) release from mouse peritoneal macrophages and TNF-alpha release from rat peripheral blood mononuclear cells.
Kim BH; Kang KS; Lee YS
Toxicol Lett; 2004 Apr; 150(2):191-201. PubMed ID: 15093674
[TBL] [Abstract][Full Text] [Related]
20. Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors.
Gray PA; Warner TD; Vojnovic I; Del Soldato P; Parikh A; Scadding GK; Mitchell JA
Br J Pharmacol; 2002 Dec; 137(7):1031-8. PubMed ID: 12429575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
